Physician
Altenburger, Dana
Altenburger, Dana was paid $2.04M by Medicaid between Jan 2018 and Dec 2024, across 124 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 14% of everything it billed.
33Billing provider infoALTENBURGER, DANA
NORMAL, IL 61761
NORMAL, IL 61761
33aNPI1003067661assigned 10/01/2008
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$2.04M
24GClaims422,813
24DCodes billed124
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Rank by total paid#36 of 398
Median peer was paid$66K
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 38,513 | $149K | |
| 2019 | 50,053 | $193K | |
| 2020 | 59,114 | $248K | |
| 2021 | 66,157 | $345K | |
| 2022 | 69,588 | $375K | |
| 2023 | 78,591 | $414K | |
| 2024incomplete | 60,797 | $320K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 14% | 54,370 | 37,619 | $278K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.5% | 53,762 | 35,474 | $153K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 6.8% | 5,749 | 4,865 | $140K |
| 84443 | Thyroid stimulating hormone (TSH) | 5.1% | 13,064 | 11,806 | $105K |
| 83735 | 5.1% | 30,864 | 17,195 | $104K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.6% | 1,474 | 1,406 | $74K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.0% | 2,808 | 2,666 | $62K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.0% | 2,811 | 2,675 | $62K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.0% | 2,791 | 2,654 | $61K |
| 84484 | 2.9% | 12,146 | 8,368 | $60K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.7% | 13,462 | 6,841 | $55K |
| 87040 | 2.3% | 4,215 | 2,980 | $47K |
112 more codes
| 83880 | 2.1% | 4,169 | $44K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.1% | 8,356 | $42K |
| 85027 | 2.0% | 14,566 | $42K | |
| 81001 | 1.8% | 19,476 | $38K | |
| 83690 | 1.8% | 11,240 | $38K | |
| 87641 | 1.7% | 1,556 | $34K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.5% | 1,072 | $32K |
| 83605 | 1.5% | 6,177 | $31K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.4% | 2,350 | $28K |
| 80061 | Lipid panel | 1.4% | 7,602 | $28K |
| 81025 | 1.2% | 11,497 | $24K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.0% | 6,807 | $21K |
| 82803 | 1.0% | 2,401 | $21K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.0% | 2,389 | $20K |
| 87186 | 1.0% | 3,491 | $20K | |
| 85730 | <1% | 5,979 | $18K | |
| 85610 | <1% | 9,324 | $18K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 455 | $16K |
| 87070 | <1% | 4,459 | $14K | |
| 82607 | <1% | 2,233 | $13K | |
| 82962 | <1% | 6,051 | $12K | |
| 87400 | <1% | 1,926 | $12K | |
| 84439 | <1% | 2,593 | $11K | |
| 85379 | <1% | 2,977 | $11K | |
| 86140 | <1% | 4,774 | $11K | |
| 84702 | <1% | 2,387 | $11K | |
| 82728 | <1% | 2,523 | $10K | |
| 87806 | <1% | 1,010 | $10K | |
| 86901 | <1% | 4,456 | $10K | |
| 82948 | <1% | 5,789 | $10K | |
| 86803 | <1% | 1,103 | $9K | |
| 86850 | <1% | 3,049 | $9K | |
| 83655 | <1% | 1,455 | $9K | |
| 81003 | <1% | 9,845 | $8K | |
| 82550 | <1% | 2,535 | $7K | |
| 85007 | <1% | 4,233 | $7K | |
| 87075 | <1% | 1,045 | $7K | |
| 86900 | <1% | 3,907 | $7K | |
| 80074 | <1% | 342 | $6K | |
| 84145 | <1% | 2,331 | $6K | |
| 84100 | <1% | 2,751 | $6K | |
| 88304 | <1% | 274 | $6K | |
| 83540 | <1% | 1,806 | $6K | |
| 83550 | <1% | 1,337 | $6K | |
| 82570 | <1% | 2,286 | $5K | |
| 80069 | <1% | 1,150 | $5K | |
| 87340 | <1% | 705 | $5K | |
| 85378 | <1% | 1,163 | $4K | |
| 86003 | <1% | 118 | $4K | |
| 87420 | <1% | 498 | $4K | |
| 87088 | <1% | 653 | $4K | |
| 87480 | <1% | 302 | $4K | |
| 87510 | <1% | 303 | $4K | |
| 85652 | <1% | 2,595 | $3K | |
| 87205 | <1% | 1,743 | $3K | |
| 82746 | <1% | 525 | $3K | |
| 86038 | <1% | 406 | $3K | |
| 85018 | <1% | 2,676 | $3K | |
| 86780 | <1% | 356 | $3K | |
| 82043 | <1% | 1,425 | $3K | |
| 87660 | <1% | 342 | $3K | |
| 84030 | <1% | 1,069 | $3K | |
| 82247 | <1% | 915 | $2K | |
| 86592 | <1% | 1,092 | $2K | |
| 84550 | <1% | 850 | $2K | |
| 88307 | <1% | 23 | $2K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 110 | $1K |
| 85014 | <1% | 1,260 | $1K | |
| 84481 | <1% | 265 | $1K | |
| 86480 | <1% | 101 | $1K | |
| 86880 | <1% | 340 | $963.52 | |
| 80305 | <1% | 213 | $950.81 | |
| 82784 | <1% | 136 | $945.57 | |
| 82248 | <1% | 411 | $913.23 | |
| 80076 | <1% | 227 | $904.62 | |
| 83615 | <1% | 314 | $897.84 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 62 | $840.00 |
| 86920 | <1% | 198 | $822.50 | |
| 83970 | <1% | 51 | $793.56 | |
| 87427 | <1% | 58 | $684.13 | |
| 87210 | <1% | 302 | $683.25 | |
| 84156 | <1% | 394 | $462.59 | |
| 87430 | <1% | 50 | $390.61 | |
| 84703 | <1% | 104 | $366.29 | |
| 83001 | <1% | 40 | $363.60 | |
| 84403 | <1% | 28 | $350.00 | |
| 83930 | <1% | 115 | $344.84 | |
| 87045 | <1% | 59 | $334.25 | |
| 84146 | <1% | 44 | $295.24 | |
| 84402 | <1% | 31 | $284.27 | |
| 86762 | <1% | 69 | $278.47 | |
| 82075 | <1% | 79 | $262.76 | |
| 87324 | <1% | 33 | $258.21 | |
| 86431 | <1% | 75 | $236.53 | |
| 87899 | <1% | 34 | $213.47 | |
| 87046 | <1% | 59 | $174.74 | |
| 82330 | <1% | 20 | $153.64 | |
| 82009 | <1% | 102 | $131.72 | |
| 84144 | <1% | 28 | $127.76 | |
| 82010 | <1% | 38 | $114.40 | |
| 83520 | <1% | 13 | $107.78 | |
| 82533 | <1% | 16 | $107.36 | |
| 84153 | <1% | 13 | $85.80 | |
| 82977 | <1% | 30 | $81.00 | |
| 82565 | <1% | 41 | $72.23 | |
| 82950 | <1% | 27 | $60.58 | |
| 86308 | <1% | 25 | $60.00 | |
| 80051 | <1% | 12 | $30.87 | |
| 85045 | <1% | 14 | $18.34 | |
| 80320 | <1% | 1,915 | $11.57 | |
| 80329 | 0% | 250 | $0.00 | |
| 87077 | 0% | 198 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.